Stefano Molica
Prevalence of BTK and PLCG2 Mutations in BTK Inhibitor Treated CLL Patients Who Experience Disease Progression: A Meta-Analysis
Molica, Stefano; Allsup, David; Giannarelli, Diana
Citation
Molica, S., Allsup, D., & Giannarelli, D. (2024, December). Prevalence of BTK and PLCG2 Mutations in BTK Inhibitor Treated CLL Patients Who Experience Disease Progression: A Meta-Analysis. Presented at American Society of Haematology, San Diego
Presentation Conference Type | Conference Abstract |
---|---|
Conference Name | American Society of Haematology |
Start Date | Dec 6, 2024 |
End Date | Dec 10, 2024 |
Acceptance Date | Nov 5, 2024 |
Online Publication Date | Nov 5, 2024 |
Publication Date | Nov 5, 2024 |
Deposit Date | Dec 16, 2024 |
Publicly Available Date | Nov 6, 2025 |
Journal | Blood |
Print ISSN | 0006-4971 |
Publisher | American Society of Hematology |
Peer Reviewed | Peer Reviewed |
Volume | 144 |
Issue | Supplement 1 |
Pages | 4630-4630 |
DOI | https://doi.org/10.1182/blood-2024-200896 |
Public URL | https://hull-repository.worktribe.com/output/4963939 |
Files
This file is under embargo until Nov 6, 2025 due to copyright reasons.
Contact D.J.Allsup@hull.ac.uk to request a copy for personal use.
You might also like
Epcoritamab in B-cell malignancies: current status and prospects
(2024)
Journal Article
Network meta-analysis of upfront fixed-duration therapies in chronic lymphocytic leukemia
(2024)
Journal Article
Chronic Lymphocytic Leukemia Care and Beyond: Navigating the Needs of Long-Term Survivors
(2025)
Journal Article